Virus inactivation in blood components by photoactive phenothiazine dyes

Transfusion Medicine Reviews

Volumn 16, Issue 1, 2002, Pages 61-66

  Wagner, Stephen J ^a,b  

^a AMERICAN RED CROSS BLOOD SERVICES   (United States)

^b AMERICAN RED CROSS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHENOTHIAZINE;

ANTIVIRAL ACTIVITY; ARTICLE; BLOOD STORAGE; BLOOD TRANSFUSION; DRUG STRUCTURE; HUMAN; HUMAN CELL; INFECTION PREVENTION; NONHUMAN; PHOTODYNAMIC THERAPY; VIRUS INACTIVATION;

EID: 0036144173     PISSN: 08877963     EISSN: None     Source Type: Journal    
DOI: 10.1053/tmrv.2002.29405     Document Type: Article

References (53)

1. The risk of transfusion-transmitted viral infections
2. Nucleic acid testing for transfusion-transmissible agents
3. Hepatitis C virus transmission by a blood donation negative in nucleic acid amplification tests for viral RNA
4. Photodynamic action of certain dyes on the inactivation of staphylococcus bacteriophage
5. The photodynamic action of methylene blue on certain viruses
6. Methylene blue photosensitised strand cleavage of DNA: Effects of dye binding and oxygen
7. Linear dichroism and polarized fluorescence of dye-complexed DNA fibers
8. Ionic strength dependence of the binding of methylene blue to chromatin and calf thymus DNA
9. Electrochemistry of methylene blue bound to a DNA-modified electrode
10. Factors affecting virus photoinactivation by a series of phenothiazine dyes
11. Time-resolved studies of singletoxygen emission from L1210 leukemia cells labeled with 5-(N-Hexadecanoyl)amino eosin. A comparison with a one-dimensional model of singlet-oxygen diffusion and quenching
12. The photodynamic reaction of methylene blue with deoxyribonucleic acid
13. Base-specific reactions useful for DNA sequencing: Methylene blue - Sensitized photooxidation of guanine and osmium tetraoxide modification of thymine
14. Methylene blue and rose bengal photoinactivation of RNA bacteriophages: Comparative studies of 8-oxoguanine formation in isolated RNA
15. Target structures for HIV-1 inactivation by methylene blue and light
16. Analysis of viral DNA, protein and envelope damage after methylene blue, phthalocyanine derivative or merocyanine 540 photosensitization
17. Infection cycle of herpes viruses after photodynamic treatment with methylene blue and light
18. Potential mechanisms of photodynamic inactivation of virus by methylene blue. I. RNA-protein crosslinks and other oxidative lesions in Q beta bacteriophage
19. Q beta bacteriophage photoinactivated by methylene blue plus light involves inactivation of its genomic RNA
20. Photodynamic treatment of adenoviral vectors with visible light: An easy and convenient method for viral inactivation
21. Elucidation of the HIV-1 virucidal mechanism of methylene blue photosensitization and the effect on primary isolates
22. Inactivation of viruses by the photodynamic action of toluidine blue
23. Photoinactivation of viruses in human fresh plasma by phenothiazine dyes in combination with visible light
24. Influence of methylene blue photoinactivation treatment on coagulation factors from fresh frozen plasma, cryoprecipitates and cryosupernatants
25. Factor VIII/von Willebrand factor complex in methylene blue-treated fresh plasma
26. The effect of methylene blue phototreatment on plasma proteins and in vitro coagulation capability of single-donor fresh-frozen plasma
27. Photo-oxidation of histidine as a probe for aminoterminal conformational changes during fibrinogen-fibrin conversion
28. Reactivity of singlet oxygen toward amino acids and peptides
29. Methemoglobinemia and methemoglobinproducing compounds
30. Mutagenicity of low molecular substances in various superoxide generating systems
31. Mammalian genotoxicity assessment of methylene blue in plasma: Implications for virus inactivation
32. Differential sensitivities of viruses in red cell suspensions to methylene blue photosensitization
33. Comparison of methylene blue and methylene violet for photoinactivation of intracellular and extracellular virus in red cell suspensions
34. Contamination of fresh-frozen plasma with viable white cells and proliferable stem cells
35. Elimination of both cell-free and cell-associated HIV infectivity in plasma by a filtration/methylene blue photoinactivation system
36. Removal of methylene blue from plasma via an adsorbent filter
37. Methylene blue/light treatment of virus inactivated plasma: Production and clinical experience
38. Photodynamic virus inactivation of thrombocyte concentrates by phenothiazine dyes
39. Red cell membrane alterations associated with virucidal methylene blue phototreatment
40. Photonuclease activity of Taylor's blue
41. Preservation of red cell properties after virucidal phototreatment with dimethylmethylene blue
42. Comparison of the sensitivity of duck hepatitis B and vesicular stomatitis virus to photoinactivation by dimethylmethylene blue
43. Selective protection of RBC's against photodynamic damage by the band 3 ligand dipyridamole
44. Photoinactivation of leukocytes in erythrocyte suspensions: Comparison of methylene blue and dimethylmethylene blue
45. Increased cytotoxicity and phototoxicity in the methylene blue series via chromophore methylation
46. Phenothiazine Photosensitizers. III. Activity of methylene blue derivatives against pigmented melanoma cell lines
47. The use of riboflavin for the inactivation of pathogens in blood products